KM Financial Solutions | UPDATE 1-Drug firm Concordia overcharged Britain’s health service with 6,000 pct price rise
3897
post-template-default,single,single-post,postid-3897,single-format-standard,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-child-theme-ver-1.0.0,qode-theme-ver-11.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.2.1,vc_responsive
 

UPDATE 1-Drug firm Concordia overcharged Britain’s health service with 6,000 pct price rise

UPDATE 1-Drug firm Concordia overcharged Britain’s health service with 6,000 pct price rise

LONDON, Nov 21 (Reuters) – Drug company Concordia
overcharged Britain’s health service millions of pounds for an
essential thyroid drug by abusing its position as the only
supplier, the country’s Competition and Markets Authority said
on Tuesday.

No Comments

Post A Comment